ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr | ₹3,245 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹3,995 Cr |
Mar2023 | ₹3,707 Cr |
Mar2022 | ₹4,805 Cr |
Mar2021 | ₹3,604 Cr |
Mar2020 | ₹3,245 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3,995 Cr | 7.75 | |
Mar2023 | ₹3,707 Cr | -22.85 | |
Mar2022 | ₹4,805 Cr | 33.33 | |
Mar2021 | ₹3,604 Cr | 11.08 | |
Mar2020 | ₹3,245 Cr | - |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹58,422.2 Cr | -1.1% | 0.9% | -2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | -1.1% |
0.9% |
-2% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses